{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,9]],"date-time":"2026-08-09T10:42:12Z","timestamp":1786272132892,"version":"build-2736575974"},"reference-count":337,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82070647"],"award-info":[{"award-number":["82070647"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82200972"],"award-info":[{"award-number":["82200972"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.lfs.2023.121943","type":"journal-article","created":{"date-parts":[[2023,7,15]],"date-time":"2023-07-15T00:57:48Z","timestamp":1689382668000},"page":"121943","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["The emerging significance of mitochondrial targeted strategies in NAFLD treatment"],"prefix":"10.1016","volume":"329","author":[{"given":"Tao","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingli","family":"Nie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiliang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.lfs.2023.121943_bb0005","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1159\/000443344","article-title":"EASL-EASD-EASO clinical practice guidelines for the management of non-alcoholic fatty liver disease","volume":"9","year":"2016","journal-title":"Obes. Facts"},{"issue":"10290","key":"10.1016\/j.lfs.2023.121943_bb0010","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/S0140-6736(20)32511-3","article-title":"Non-alcoholic fatty liver disease","volume":"397","author":"Powell","year":"2021","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.lfs.2023.121943_bb0015","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.eprac.2022.03.010","volume":"28","author":"Cusi","year":"2022","journal-title":"Endocr. Pract."},{"issue":"4","key":"10.1016\/j.lfs.2023.121943_bb0020","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","article-title":"The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review","volume":"77","author":"Younossi","year":"2023","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.lfs.2023.121943_bb0025","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.lfs.2023.121943_bb0030","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/s41575-020-00381-6","article-title":"Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention","volume":"18","author":"Huang","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"6","key":"10.1016\/j.lfs.2023.121943_bb0035","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1002\/hep.30664","article-title":"The natural history of advanced fibrosis due to nonalcoholic steatohepatitis: data from the simtuzumab trials","volume":"70","author":"Sanyal","year":"2019","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.lfs.2023.121943_bb0040","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.jhep.2017.09.021","article-title":"Hypertension, diabetes, atherosclerosis and NASH: cause or consequence?","volume":"68","author":"Lonardo","year":"2018","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.lfs.2023.121943_bb0045","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","article-title":"A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement","volume":"73","author":"Eslam","year":"2020","journal-title":"J. Hepatol."},{"issue":"4","key":"10.1016\/j.lfs.2023.121943_bb0050","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1111\/liv.15197","article-title":"The NAFLD-MAFLD debate: is there a consensus-on-consensus methodology?","volume":"42","author":"Fouad","year":"2022","journal-title":"Liver Int."},{"issue":"2","key":"10.1016\/j.lfs.2023.121943_bb0055","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/liv.14739","article-title":"The NAFLD-MAFLD debate: eminence vs evidence","volume":"41","author":"Fouad","year":"2021","journal-title":"Liver Int."},{"issue":"5","key":"10.1016\/j.lfs.2023.121943_bb0060","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1002\/hep.31150","article-title":"Epidemiological features of NAFLD from 1999 to 2018 in China","volume":"71","author":"Zhou","year":"2020","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.lfs.2023.121943_bb0065","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.jhep.2019.06.021","article-title":"The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: a systematic review and meta-analysis","volume":"71","author":"Younossi","year":"2019","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.lfs.2023.121943_bb0070","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1053\/j.gastro.2010.09.038","article-title":"Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study","volume":"140","author":"Williams","year":"2011","journal-title":"Gastroenterology"},{"issue":"8","key":"10.1016\/j.lfs.2023.121943_bb0075","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S2468-1253(20)30077-7","article-title":"Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis","volume":"5","author":"Ye","year":"2020","journal-title":"Lancet Gastroenterol. Hepatol."},{"issue":"10","key":"10.1016\/j.lfs.2023.121943_bb0080","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0140908","article-title":"The prevalence of non-alcoholic fatty liver disease in children and adolescents: a systematic review and meta-analysis","volume":"10","author":"Anderson","year":"2015","journal-title":"PLoS One"},{"issue":"27","key":"10.1016\/j.lfs.2023.121943_bb0085","doi-asserted-by":"crossref","first-page":"2974","DOI":"10.3748\/wjg.v24.i27.2974","article-title":"Pathogenesis of non-alcoholic fatty liver disease in children and adolescence: from \u201ctwo hit theory\u201d to \u201cmultiple hit model\u201d","volume":"24","author":"Fang","year":"2018","journal-title":"World J. Gastroenterol."},{"issue":"4","key":"10.1016\/j.lfs.2023.121943_bb0090","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/S0016-5085(98)70599-2","article-title":"Steatohepatitis: a tale of two \u201chits\u201d?","volume":"114","author":"Day","year":"1998","journal-title":"Gastroenterology"},{"issue":"8","key":"10.1016\/j.lfs.2023.121943_bb0095","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.metabol.2015.12.012","article-title":"The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)","volume":"65","author":"Buzzetti","year":"2016","journal-title":"Metab. Clin. Exp."},{"issue":"8","key":"10.1016\/j.lfs.2023.121943_bb0100","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/s41574-022-00675-6","article-title":"Macrophage functional diversity in NAFLD - more than inflammation","volume":"18","author":"Barreby","year":"2022","journal-title":"Nat. Rev. Endocrinol."},{"issue":"1","key":"10.1016\/j.lfs.2023.121943_bb0105","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3803\/EnM.2018.33.1.33","article-title":"Association of adipokines with development and progression of nonalcoholic fatty liver disease","volume":"33","author":"Boutari","year":"2018","journal-title":"Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.lfs.2023.121943_bb0110","doi-asserted-by":"crossref","DOI":"10.3390\/biom12010056","article-title":"Understanding the role of the gut microbiome and microbial metabolites in non-alcoholic fatty liver disease: current evidence and perspectives","volume":"12","author":"Vallianou","year":"2021","journal-title":"Biomolecules"},{"issue":"8","key":"10.1016\/j.lfs.2023.121943_bb0115","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/nrendo.2017.42","article-title":"Endocrine-disrupting chemicals and fatty liver disease","volume":"13","author":"Foulds","year":"2017","journal-title":"Nat. Rev. Endocrinol."},{"issue":"4","key":"10.1016\/j.lfs.2023.121943_bb0120","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1055\/s-0033-1358525","article-title":"PNPLA3-associated steatohepatitis: toward a gene-based classification of fatty liver disease","volume":"33","author":"Krawczyk","year":"2013","journal-title":"Semin. Liver Dis."},{"issue":"4","key":"10.1016\/j.lfs.2023.121943_bb0125","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1053\/j.gastro.2015.01.038","article-title":"TM6SF2: catch-22 in the fight against nonalcoholic fatty liver disease and cardiovascular disease?","volume":"148","author":"Kahali","year":"2015","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.lfs.2023.121943_bb0130","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0185490","article-title":"Risk estimation model for nonalcoholic fatty liver disease in the Japanese using multiple genetic markers","volume":"13","author":"Kawaguchi","year":"2018","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.lfs.2023.121943_bb0135","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1053\/j.gastro.2016.01.032","article-title":"The MBOAT7-TMC4 variant rs641738 increases risk of nonalcoholic fatty liver disease in individuals of European descent","volume":"150","author":"Mancina","year":"2016","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.lfs.2023.121943_bb0140","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1008629","article-title":"A missense variant in mitochondrial amidoxime reducing component 1 gene and protection against liver disease","volume":"16","author":"Emdin","year":"2020","journal-title":"PLoS Genet."},{"key":"10.1016\/j.lfs.2023.121943_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2020.101122","article-title":"Nonalcoholic fatty liver disease (NAFLD) from pathogenesis to treatment concepts in humans","volume":"50","author":"Pafili","year":"2021","journal-title":"Mol. Metab."},{"issue":"12","key":"10.1016\/j.lfs.2023.121943_bb0150","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1111\/apt.15738","article-title":"Review article: the emerging role of genetics in precision medicine for patients with non-alcoholic steatohepatitis","volume":"51","author":"Carlsson","year":"2020","journal-title":"Aliment. Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.lfs.2023.121943_bb0155","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/cbf.3763","article-title":"Epigenetics and mitochondrial dysfunction insights into the impact of the progression of non-alcoholic fatty liver disease","volume":"41","author":"Guha","year":"2023","journal-title":"Cell Biochem. Funct."},{"issue":"5","key":"10.1016\/j.lfs.2023.121943_bb0160","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1002\/hep.24001","article-title":"Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis","volume":"52","author":"Tilg","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.lfs.2023.121943_bb0165","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/387626","article-title":"Mitochondrial roles and cytoprotection in chronic liver injury","volume":"2012","author":"Degli Esposti","year":"2012","journal-title":"Biochem. Res. Int."},{"issue":"1\u20132","key":"10.1016\/j.lfs.2023.121943_bb0170","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.mam.2007.09.014","article-title":"Mitochondrial involvement in non-alcoholic steatohepatitis","volume":"29","author":"Serviddio","year":"2008","journal-title":"Mol. Asp. Med."},{"issue":"13","key":"10.1016\/j.lfs.2023.121943_bb0175","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.3748\/wjg.v29.i13.1982","article-title":"Research progress on the mitochondrial mechanism of age-related non-alcoholic fatty liver","volume":"29","author":"Wang","year":"2023","journal-title":"World J. Gastroenterol."},{"issue":"4","key":"10.1016\/j.lfs.2023.121943_bb0180","doi-asserted-by":"crossref","DOI":"10.3390\/biology12040595","article-title":"From non-alcoholic fatty liver to hepatocellular carcinoma: a story of (mal)adapted mitochondria","volume":"12","author":"Amorim","year":"2023","journal-title":"Biology"},{"issue":"2","key":"10.1016\/j.lfs.2023.121943_bb0185","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.jhep.2022.09.020","article-title":"Mitochondrial alterations in fatty liver diseases","volume":"78","author":"Fromenty","year":"2023","journal-title":"J. Hepatol."},{"issue":"7","key":"10.1016\/j.lfs.2023.121943_bb0190","doi-asserted-by":"crossref","first-page":"3156","DOI":"10.3390\/cimb44070218","article-title":"Mitochondrial dysfunction and chronic liver disease","volume":"44","author":"Zhang","year":"2022","journal-title":"Curr. Issues Mol. Biol."},{"issue":"13","key":"10.1016\/j.lfs.2023.121943_bb0195","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23137280","article-title":"Mitochondrial dysfunction plays central role in nonalcoholic fatty liver disease","volume":"23","author":"Ramanathan","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.lfs.2023.121943_bb0200","doi-asserted-by":"crossref","first-page":"C670","DOI":"10.1152\/ajpcell.00213.2006","article-title":"The mitochondrial energy transduction system and the aging process","volume":"292","author":"Navarro","year":"2007","journal-title":"Am. J. Physiol. Cell Physiol."},{"issue":"6","key":"10.1016\/j.lfs.2023.121943_bb0205","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.cmet.2011.11.004","article-title":"Excessive hepatic mitochondrial TCA cycle and gluconeogenesis in humans with nonalcoholic fatty liver disease","volume":"14","author":"Sunny","year":"2011","journal-title":"Cell Metab."},{"issue":"6","key":"10.1016\/j.lfs.2023.121943_bb0210","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1194\/jlr.M023382","article-title":"Elevated TCA cycle function in the pathology of diet-induced hepatic insulin resistance and fatty liver","volume":"53","author":"Satapati","year":"2012","journal-title":"J. Lipid Res."},{"issue":"5","key":"10.1016\/j.lfs.2023.121943_bb0215","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.cmet.2015.04.004","article-title":"Adaptation of hepatic mitochondrial function in humans with non-alcoholic fatty liver is lost in steatohepatitis","volume":"21","author":"Koliaki","year":"2015","journal-title":"Cell Metab."},{"issue":"17","key":"10.1016\/j.lfs.2023.121943_bb0220","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.3748\/wjg.v26.i17.1993","article-title":"Metabolic inflammation as an instigator of fibrosis during non-alcoholic fatty liver disease","volume":"26","author":"Katsarou","year":"2020","journal-title":"World J. Gastroenterol."},{"issue":"3","key":"10.1016\/j.lfs.2023.121943_bb0225","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1053\/j.gastro.2010.05.039","article-title":"Fatty acid metabolism in the liver, measured by positron emission tomography, is increased in obese individuals","volume":"139","author":"Iozzo","year":"2010","journal-title":"Gastroenterology"},{"issue":"5\u20136","key":"10.1016\/j.lfs.2023.121943_bb0230","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.mito.2008.07.008","article-title":"Differential alterations in mitochondrial function induced by a choline-deficient diet: understanding fatty liver disease progression","volume":"8","author":"Teodoro","year":"2008","journal-title":"Mitochondrion"},{"issue":"9","key":"10.1016\/j.lfs.2023.121943_bb0235","doi-asserted-by":"crossref","first-page":"5692","DOI":"10.1074\/jbc.274.9.5692","article-title":"Obesity induces expression of uncoupling protein-2 in hepatocytes and promotes liver ATP depletion","volume":"274","author":"Chavin","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.lfs.2023.121943_bb0240","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/7534285","article-title":"Renalase attenuates mouse fatty liver ischemia\/reperfusion injury through mitigating oxidative stress and mitochondrial damage via activating SIRT1","volume":"2019","author":"Zhang","year":"2019","journal-title":"Oxidative Med. Cell. Longev."},{"issue":"2","key":"10.1016\/j.lfs.2023.121943_bb0245","first-page":"466","article-title":"Hepatic ATP reserve and efficiency of replenishing: comparison between obese and nonobese normal individuals","volume":"98","author":"Nair","year":"2003","journal-title":"Am. J. Gastroenterol."},{"issue":"5","key":"10.1016\/j.lfs.2023.121943_bb0250","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1002\/hep.32324","article-title":"Compromised hepatic mitochondrial fatty acid oxidation and reduced markers of mitochondrial turnover in human NAFLD","volume":"76","author":"Moore","year":"2022","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.lfs.2023.121943_bb0255","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1002\/hep.1840380426","article-title":"Defective hepatic mitochondrial respiratory chain in patients with nonalcoholic steatohepatitis","volume":"38","author":"P\u00e9rez-Carreras","year":"2003","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.lfs.2023.121943_bb0260","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1085\/jgp.201210772","article-title":"Glutathione\/thioredoxin systems modulate mitochondrial H2O2 emission: an experimental-computational study","volume":"139","author":"Aon","year":"2012","journal-title":"J. Gen. Physiol."},{"issue":"3","key":"10.1016\/j.lfs.2023.121943_bb0265","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1152\/physrev.00026.2013","article-title":"Mitochondrial reactive oxygen species (ROS) and ROS-induced ROS release","volume":"94","author":"Zorov","year":"2014","journal-title":"Physiol. Rev."},{"issue":"4","key":"10.1016\/j.lfs.2023.121943_bb0270","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.freeradbiomed.2009.05.004","article-title":"Mitochondria and reactive oxygen species","volume":"47","author":"Kowaltowski","year":"2009","journal-title":"Free Radic. Biol. Med."},{"issue":"5","key":"10.1016\/j.lfs.2023.121943_bb0275","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1172\/JCI23621","article-title":"Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease","volume":"115","author":"Donnelly","year":"2005","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.lfs.2023.121943_bb0280","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1146\/annurev-pathol-020117-043617","article-title":"Recent insights into the pathogenesis of nonalcoholic fatty liver disease","volume":"13","author":"Arab","year":"2018","journal-title":"Annu. Rev. Pathol."},{"issue":"4","key":"10.1016\/j.lfs.2023.121943_bb0285","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1002\/hep.26226","article-title":"Mitochondrial adaptations and dysfunctions in nonalcoholic fatty liver disease","volume":"58","author":"Begriche","year":"2013","journal-title":"Hepatology"},{"issue":"8","key":"10.1016\/j.lfs.2023.121943_bb0290","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/j.bbabio.2007.04.005","article-title":"Fatty acids decrease mitochondrial generation of reactive oxygen species at the reverse electron transport but increase it at the forward transport","volume":"1767","author":"Sch\u00f6nfeld","year":"2007","journal-title":"Biochim. Biophys. Acta"},{"issue":"1\u20132","key":"10.1016\/j.lfs.2023.121943_bb0295","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0891-5849(99)00034-9","article-title":"Arachidonic acid interaction with the mitochondrial electron transport chain promotes reactive oxygen species generation","volume":"27","author":"Cocco","year":"1999","journal-title":"Free Radic. Biol. Med."},{"issue":"Pt 3","key":"10.1016\/j.lfs.2023.121943_bb0300","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1042\/BJ20041703","article-title":"Inhibitory effect of palmitate on the mitochondrial NADH:ubiquinone oxidoreductase (complex I) as related to the active-de-active enzyme transition","volume":"387","author":"Loskovich","year":"2005","journal-title":"Biochem. J."},{"issue":"5","key":"10.1016\/j.lfs.2023.121943_bb0305","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s11745-997-0064-6","article-title":"Effect of docosahexaenoic acid on mouse mitochondrial membrane properties","volume":"32","author":"Stillwell","year":"1997","journal-title":"Lipids"},{"issue":"2","key":"10.1016\/j.lfs.2023.121943_bb0310","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0014-5793(99)01009-1","article-title":"Refsum disease diagnostic marker phytanic acid alters the physical state of membrane proteins of liver mitochondria","volume":"457","author":"Sch\u00f6nfeld","year":"1999","journal-title":"FEBS Lett."},{"issue":"10","key":"10.1016\/j.lfs.2023.121943_bb0315","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0077088","article-title":"Diet-sensitive sources of reactive oxygen species in liver mitochondria: role of very long chain acyl-CoA dehydrogenases","volume":"8","author":"Cardoso","year":"2013","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.lfs.2023.121943_bb0320","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1111\/j.1572-0241.2005.41500.x","article-title":"Systemic markers of lipid peroxidation and antioxidants in patients with nonalcoholic fatty liver disease","volume":"100","author":"Yesilova","year":"2005","journal-title":"Am. J. Gastroenterol."},{"issue":"5","key":"10.1016\/j.lfs.2023.121943_bb0325","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/S0168-8278(01)00192-1","article-title":"Non-alcoholic fatty liver disease in an area of southern Italy: main clinical, histological, and pathophysiological aspects","volume":"35","author":"Loguercio","year":"2001","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.lfs.2023.121943_bb0330","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0168-8278(02)00073-9","article-title":"In situ detection of lipid peroxidation and oxidative DNA damage in non-alcoholic fatty liver diseases","volume":"37","author":"Seki","year":"2002","journal-title":"J. Hepatol."},{"issue":"4","key":"10.1016\/j.lfs.2023.121943_bb0335","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1381\/0960892053723493","article-title":"Lipid peroxidation in bariatric candidates with nonalcoholic fatty liver disease (NAFLD) -- preliminary findings","volume":"15","author":"Oliveira","year":"2005","journal-title":"Obes. Surg."},{"issue":"3","key":"10.1016\/j.lfs.2023.121943_bb0340","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1590\/S0004-28032015000300014","article-title":"Influence of oxidative stress and obesity in patients with nonalcoholic steatohepatitis","volume":"52","author":"Leghi","year":"2015","journal-title":"Arq. Gastroenterol."},{"issue":"4","key":"10.1016\/j.lfs.2023.121943_bb0345","doi-asserted-by":"crossref","first-page":"471","DOI":"10.3892\/ijmm_00000487","article-title":"Oxidative stress parameters in paediatric non-alcoholic fatty liver disease","volume":"26","author":"Nobili","year":"2010","journal-title":"Int. J. Mol. Med."},{"issue":"5","key":"10.1016\/j.lfs.2023.121943_bb0350","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1053\/gast.2001.23256","article-title":"Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities","volume":"120","author":"Sanyal","year":"2001","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.lfs.2023.121943_bb0355","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1042\/CS20030285","article-title":"Oxidative stress-related parameters in the liver of non-alcoholic fatty liver disease patients","volume":"106","author":"Videla","year":"2004","journal-title":"Clin. Sci."},{"issue":"4","key":"10.1016\/j.lfs.2023.121943_bb0360","doi-asserted-by":"crossref","first-page":"361","DOI":"10.5152\/tjg.2016.16106","article-title":"Role of oxidative stress and insulin resistance in disease severity of non-alcoholic fatty liver disease","volume":"27","author":"K\u00f6ro\u011flu","year":"2016","journal-title":"Turk J Gastroenterol"},{"issue":"1","key":"10.1016\/j.lfs.2023.121943_bb0365","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0168-8278(02)00331-8","article-title":"Serum thioredoxin levels as a predictor of steatohepatitis in patients with nonalcoholic fatty liver disease","volume":"38","author":"Sumida","year":"2003","journal-title":"J. Hepatol."},{"issue":"2","key":"10.1016\/j.lfs.2023.121943_bb0370","doi-asserted-by":"crossref","first-page":"C413","DOI":"10.1152\/ajpcell.00362.2007","article-title":"Mitochondrial DNA damage triggers mitochondrial-superoxide generation and apoptosis","volume":"294","author":"Ricci","year":"2008","journal-title":"Am. J. Physiol. Cell Physiol."},{"issue":"4","key":"10.1016\/j.lfs.2023.121943_bb0375","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1124\/mol.108.048405","article-title":"Patupilone-induced apoptosis is mediated by mitochondrial reactive oxygen species through Bim relocalization to mitochondria","volume":"74","author":"Khawaja","year":"2008","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.lfs.2023.121943_bb0380","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.freeradbiomed.2020.02.025","article-title":"Role of oxidative stress in the pathogenesis of nonalcoholic fatty liver disease","volume":"152","author":"Chen","year":"2020","journal-title":"Free Radic. Biol. Med."},{"issue":"9","key":"10.1016\/j.lfs.2023.121943_bb0385","doi-asserted-by":"crossref","first-page":"4892","DOI":"10.1111\/jcmm.15194","article-title":"Mitochondrial biogenesis: an update","volume":"24","author":"Popov","year":"2020","journal-title":"J. Cell. Mol. Med."},{"issue":"3","key":"10.1016\/j.lfs.2023.121943_bb0390","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1172\/JCI27794","article-title":"PGC-1 coactivators: inducible regulators of energy metabolism in health and disease","volume":"116","author":"Finck","year":"2006","journal-title":"J. Clin. Invest."},{"issue":"4","key":"10.1016\/j.lfs.2023.121943_bb0395","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1128\/MCB.25.4.1354-1366.2005","article-title":"Control of mitochondrial transcription specificity factors (TFB1M and TFB2M) by nuclear respiratory factors (NRF-1 and NRF-2) and PGC-1 family coactivators","volume":"25","author":"Gleyzer","year":"2005","journal-title":"Mol. Cell. Biol."},{"issue":"3","key":"10.1016\/j.lfs.2023.121943_bb0400","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1042\/EBC20170100","article-title":"Mitochondrial DNA replication in mammalian cells: overview of the pathway","volume":"62","author":"Falkenberg","year":"2018","journal-title":"Essays Biochem."},{"issue":"6","key":"10.1016\/j.lfs.2023.121943_bb0405","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1210\/er.2008-0017","article-title":"Transcriptional control of energy homeostasis by the estrogen-related receptors","volume":"29","author":"Gigu\u00e8re","year":"2008","journal-title":"Endocr. Rev."},{"issue":"1","key":"10.1016\/j.lfs.2023.121943_bb0410","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s00441-016-2486-7","article-title":"The TIM23 mitochondrial protein import complex: function and dysfunction","volume":"367","author":"Demishtein-Zohary","year":"2017","journal-title":"Cell Tissue Res."},{"issue":"25","key":"10.1016\/j.lfs.2023.121943_bb0415","doi-asserted-by":"crossref","first-page":"15983","DOI":"10.1073\/pnas.252625599","article-title":"AMP kinase is required for mitochondrial biogenesis in skeletal muscle in response to chronic energy deprivation","volume":"99","author":"Zong","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"5608","key":"10.1016\/j.lfs.2023.121943_bb0420","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1126\/science.1079368","article-title":"Mitochondrial biogenesis in mammals: the role of endogenous nitric oxide","volume":"299","author":"Nisoli","year":"2003","journal-title":"Science"},{"issue":"8","key":"10.1016\/j.lfs.2023.121943_bb0425","doi-asserted-by":"crossref","DOI":"10.3390\/biom12081079","article-title":"Progress in nonalcoholic fatty liver disease: SIRT family regulates mitochondrial biogenesis","volume":"12","author":"Zeng","year":"2022","journal-title":"Biomolecules"},{"issue":"39","key":"10.1016\/j.lfs.2023.121943_bb0430","doi-asserted-by":"crossref","first-page":"14379","DOI":"10.1073\/pnas.0606714103","article-title":"Transducer of regulated CREB-binding proteins (TORCs) induce PGC-1alpha transcription and mitochondrial biogenesis in muscle cells","volume":"103","author":"Wu","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"20","key":"10.1016\/j.lfs.2023.121943_bb0435","doi-asserted-by":"crossref","first-page":"19587","DOI":"10.1074\/jbc.M408862200","article-title":"Exercise stimulates Pgc-1alpha transcription in skeletal muscle through activation of the p38 MAPK pathway","volume":"280","author":"Akimoto","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.lfs.2023.121943_bb0440","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1042\/bse0470069","article-title":"Regulation of mitochondrial biogenesis","volume":"47","author":"Jornayvaz","year":"2010","journal-title":"Essays Biochem."},{"issue":"1","key":"10.1016\/j.lfs.2023.121943_bb0445","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s10020-019-0085-2","article-title":"miR-122 promotes hepatic lipogenesis via inhibiting the LKB1\/AMPK pathway by targeting Sirt1 in non-alcoholic fatty liver disease","volume":"25","author":"Long","year":"2019","journal-title":"Mol. Med."},{"issue":"4","key":"10.1016\/j.lfs.2023.121943_bb0450","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1002\/hep.32404","article-title":"FGF4 protects the liver from nonalcoholic fatty liver disease by activating the AMP-activated protein kinase-Caspase 6 signal axis","volume":"76","author":"Song","year":"2022","journal-title":"Hepatology"},{"issue":"6478","key":"10.1016\/j.lfs.2023.121943_bb0455","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1126\/science.aay0542","article-title":"An AMPK-caspase-6 axis controls liver damage in nonalcoholic steatohepatitis","volume":"367","author":"Zhao","year":"2020","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.lfs.2023.121943_bb0460","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/s12020-014-0465-x","article-title":"Plasma levels of SIRT1 associate with non-alcoholic fatty liver disease in obese patients","volume":"49","author":"Mariani","year":"2015","journal-title":"Endocrine"},{"issue":"3","key":"10.1016\/j.lfs.2023.121943_bb0465","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1002\/hep.32332","article-title":"Notch-triggered maladaptation of liver sinusoidal endothelium aggravates nonalcoholic steatohepatitis through endothelial nitric oxide synthase","volume":"76","author":"Fang","year":"2022","journal-title":"Hepatology"},{"issue":"10","key":"10.1016\/j.lfs.2023.121943_bb0470","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1038\/nm.2449","article-title":"p38 MAPK-mediated regulation of Xbp1s is crucial for glucose homeostasis","volume":"17","author":"Lee","year":"2011","journal-title":"Nat. Med."},{"issue":"7","key":"10.1016\/j.lfs.2023.121943_bb0475","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1038\/labinvest.2011.55","article-title":"Fatty liver is associated with impaired activity of PPAR\u03b3-coactivator 1\u03b1 (PGC1\u03b1) and mitochondrial biogenesis in mice","volume":"91","author":"Aharoni-Simon","year":"2011","journal-title":"Lab. Investig."},{"issue":"9","key":"10.1016\/j.lfs.2023.121943_bb0480","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.2337\/db06-1596","article-title":"Metallothionein prevents high-fat diet induced cardiac contractile dysfunction: role of peroxisome proliferator activated receptor gamma coactivator 1alpha and mitochondrial biogenesis","volume":"56","author":"Dong","year":"2007","journal-title":"Diabetes"},{"issue":"7","key":"10.1016\/j.lfs.2023.121943_bb0485","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.2337\/diabetes.54.7.1926","article-title":"A high-fat diet coordinately downregulates genes required for mitochondrial oxidative phosphorylation in skeletal muscle","volume":"54","author":"Sparks","year":"2005","journal-title":"Diabetes"},{"issue":"7","key":"10.1016\/j.lfs.2023.121943_bb0490","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.2337\/db08-1571","article-title":"Sensitivity of lipid metabolism and insulin signaling to genetic alterations in hepatic peroxisome proliferator-activated receptor-gamma coactivator-1alpha expression","volume":"58","author":"Estall","year":"2009","journal-title":"Diabetes"},{"issue":"8","key":"10.1016\/j.lfs.2023.121943_bb0495","doi-asserted-by":"crossref","first-page":"G979","DOI":"10.1152\/ajpgi.00169.2012","article-title":"PGC-1\u03b1 overexpression results in increased hepatic fatty acid oxidation with reduced triacylglycerol accumulation and secretion","volume":"303","author":"Morris","year":"2012","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"issue":"4","key":"10.1016\/j.lfs.2023.121943_bb0500","doi-asserted-by":"crossref","DOI":"10.1002\/mnfr.201800795","article-title":"Sulforaphane improves lipid metabolism by enhancing mitochondrial function and biogenesis in vivo and in vitro","volume":"63","author":"Lei","year":"2019","journal-title":"Mol. Nutr. Food Res."},{"issue":"11","key":"10.1016\/j.lfs.2023.121943_bb0505","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1007\/s11655-021-3309-6","article-title":"Lycium barbarum polysaccharides promotes mitochondrial biogenesis and energy balance in a NAFLD cell model","volume":"28","author":"Zhang","year":"2022","journal-title":"Chin. J. Integr. Med."},{"key":"10.1016\/j.lfs.2023.121943_bb0510","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2019.101314","article-title":"Carbon monoxide releasing molecule-A1 improves nonalcoholic steatohepatitis via Nrf2 activation mediated improvement in oxidative stress and mitochondrial function","volume":"28","author":"Upadhyay","year":"2020","journal-title":"Redox Biol."},{"key":"10.1016\/j.lfs.2023.121943_bb0515","article-title":"Naringenin attenuates non-alcoholic fatty liver disease by enhancing energy expenditure and regulating autophagy via AMPK","volume":"12","author":"Yang","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.lfs.2023.121943_bb0520","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1146\/annurev-pathmechdis-012419-032711","article-title":"Mitochondrial dynamics and its involvement in disease","volume":"15","author":"Chan","year":"2020","journal-title":"Annu. Rev. Pathol."},{"issue":"7631","key":"10.1016\/j.lfs.2023.121943_bb0525","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/nature20555","article-title":"Multiple dynamin family members collaborate to drive mitochondrial division","volume":"540","author":"Lee","year":"2016","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.lfs.2023.121943_bb0530","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1083\/jcb.201007152","article-title":"Mff is an essential factor for mitochondrial recruitment of Drp1 during mitochondrial fission in mammalian cells","volume":"191","author":"Otera","year":"2010","journal-title":"J. Cell Biol."},{"issue":"5685","key":"10.1016\/j.lfs.2023.121943_bb0535","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1126\/science.1099793","article-title":"Structural basis of mitochondrial tethering by mitofusin complexes","volume":"305","author":"Koshiba","year":"2004","journal-title":"Science"},{"issue":"7641","key":"10.1016\/j.lfs.2023.121943_bb0540","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/nature21077","article-title":"MFN1 structures reveal nucleotide-triggered dimerization critical for mitochondrial fusion","volume":"542","author":"Cao","year":"2017","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.lfs.2023.121943_bb0545","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.cmet.2014.03.011","article-title":"Proteolytic cleavage of Opa1 stimulates mitochondrial inner membrane fusion and couples fusion to oxidative phosphorylation","volume":"19","author":"Mishra","year":"2014","journal-title":"Cell Metab."},{"issue":"5","key":"10.1016\/j.lfs.2023.121943_bb0550","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.molcel.2016.02.022","article-title":"Mitofusins, from mitochondria to metabolism","volume":"61","author":"Schrepfer","year":"2016","journal-title":"Mol. Cell"},{"issue":"2","key":"10.1016\/j.lfs.2023.121943_bb0555","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.tem.2015.12.001","article-title":"Mitochondrial dynamics and metabolic regulation","volume":"27","author":"Wai","year":"2016","journal-title":"Trends Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.lfs.2023.121943_bb0560","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.cmet.2013.03.002","article-title":"Mitochondrial dynamics in the regulation of nutrient utilization and energy expenditure","volume":"17","author":"Liesa","year":"2013","journal-title":"Cell Metab."},{"issue":"5","key":"10.1016\/j.lfs.2023.121943_bb0565","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1002\/hep.22183","article-title":"The lysosomal-mitochondrial axis in free fatty acid-induced hepatic lipotoxicity","volume":"47","author":"Li","year":"2008","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.lfs.2023.121943_bb0570","doi-asserted-by":"crossref","first-page":"G632","DOI":"10.1152\/ajpgi.00182.2014","article-title":"Decreasing mitochondrial fission alleviates hepatic steatosis in a murine model of nonalcoholic fatty liver disease","volume":"307","author":"Galloway","year":"2014","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"issue":"1","key":"10.1016\/j.lfs.2023.121943_bb0575","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1186\/s12916-022-02629-1","article-title":"Exercise training attenuates pulmonary inflammation and mitochondrial dysfunction in a mouse model of high-fat high-carbohydrate-induced NAFLD","volume":"20","author":"Cho","year":"2022","journal-title":"BMC Med."},{"issue":"17","key":"10.1016\/j.lfs.2023.121943_bb0580","doi-asserted-by":"crossref","first-page":"4192","DOI":"10.7150\/thno.21400","article-title":"Pro-inflammatory CXCR3 impairs mitochondrial function in experimental non-alcoholic steatohepatitis","volume":"7","author":"Du","year":"2017","journal-title":"Theranostics"},{"issue":"12","key":"10.1016\/j.lfs.2023.121943_bb0585","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1111\/hepr.13832","article-title":"Mitochondrial fission in hepatocytes as a potential therapeutic target for nonalcoholic steatohepatitis","volume":"52","author":"Miyao","year":"2022","journal-title":"Hepatol. Res."},{"issue":"3","key":"10.1016\/j.lfs.2023.121943_bb0590","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.bbrc.2019.04.069","article-title":"IDH2 protects against nonalcoholic steatohepatitis by alleviating dyslipidemia regulated by oxidative stress","volume":"514","author":"Gong","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.lfs.2023.121943_bb0595","doi-asserted-by":"crossref","DOI":"10.1111\/jpi.12450","article-title":"Effects of melatonin on fatty liver disease: the role of NR4A1\/DNA-PKcs\/p53 pathway, mitochondrial fission, and mitophagy","volume":"64","author":"Zhou","year":"2018","journal-title":"J. Pineal Res."},{"issue":"15","key":"10.1016\/j.lfs.2023.121943_bb0600","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21155469","article-title":"Cold press pomegranate seed oil attenuates dietary-obesity induced hepatic steatosis and fibrosis through antioxidant and mitochondrial pathways in obese mice","volume":"21","author":"Raffaele","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.lfs.2023.121943_bb0605","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.cell.2019.04.010","article-title":"Deficient endoplasmic reticulum-mitochondrial phosphatidylserine transfer causes liver disease","volume":"177","author":"Hern\u00e1ndez-Alvarez","year":"2019","journal-title":"Cell"},{"issue":"14","key":"10.1016\/j.lfs.2023.121943_bb0610","doi-asserted-by":"crossref","first-page":"5523","DOI":"10.1073\/pnas.1108220109","article-title":"Mitofusin 2 (Mfn2) links mitochondrial and endoplasmic reticulum function with insulin signaling and is essential for normal glucose homeostasis","volume":"109","author":"Sebasti\u00e1n","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"34","key":"10.1016\/j.lfs.2023.121943_bb0615","doi-asserted-by":"crossref","first-page":"12581","DOI":"10.1074\/jbc.RA119.007601","article-title":"In vivo stabilization of OPA1 in hepatocytes potentiates mitochondrial respiration and gluconeogenesis in a prohibitin-dependent way","volume":"294","author":"Li","year":"2019","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.lfs.2023.121943_bb0620","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1139\/apnm-2015-0470","article-title":"Exercise mitigates mitochondrial permeability transition pore and quality control mechanisms alterations in nonalcoholic steatohepatitis","volume":"41","author":"Gon\u00e7alves","year":"2016","journal-title":"Appl. Physiol. Nutr. Metab."},{"issue":"4","key":"10.1016\/j.lfs.2023.121943_bb0625","doi-asserted-by":"crossref","first-page":"475","DOI":"10.3945\/jn.113.187450","article-title":"Bitter gourd inhibits the development of obesity-associated fatty liver in C57BL\/6 mice fed a high-fat diet","volume":"144","author":"Xu","year":"2014","journal-title":"J. Nutr."},{"issue":"1","key":"10.1016\/j.lfs.2023.121943_bb0630","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1089\/rej.2005.8.3","article-title":"Selective mitochondrial autophagy, or mitophagy, as a targeted defense against oxidative stress, mitochondrial dysfunction, and aging","volume":"8","author":"Lemasters","year":"2005","journal-title":"Rejuvenation Res."},{"issue":"6","key":"10.1016\/j.lfs.2023.121943_bb0635","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.cub.2012.02.005","article-title":"Spatial parkin translocation and degradation of damaged mitochondria via mitophagy in live cortical neurons","volume":"22","author":"Cai","year":"2012","journal-title":"Curr. Biol."},{"issue":"12","key":"10.1016\/j.lfs.2023.121943_bb0640","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1089\/ars.2014.6204","article-title":"Hypoxia activation of mitophagy and its role in disease pathogenesis","volume":"22","author":"Wu","year":"2015","journal-title":"Antioxid. Redox Signal."},{"issue":"10 Pt B","key":"10.1016\/j.lfs.2023.121943_bb0645","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.1016\/j.bbamcr.2015.02.022","article-title":"Mitochondrial autophagy: origins, significance, and role of BNIP3 and NIX","volume":"1853","author":"Ney","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"issue":"4","key":"10.1016\/j.lfs.2023.121943_bb0650","first-page":"247","article-title":"Multiple ways to prevent transmission of paternal mitochondrial DNA for maternal inheritance in animals","volume":"162","author":"Sato","year":"2017","journal-title":"J. Biochem."},{"issue":"23","key":"10.1016\/j.lfs.2023.121943_bb0655","doi-asserted-by":"crossref","first-page":"19094","DOI":"10.1074\/jbc.M111.322933","article-title":"Microtubule-associated protein 1 light chain 3 (LC3) interacts with Bnip3 protein to selectively remove endoplasmic reticulum and mitochondria via autophagy","volume":"287","author":"Hanna","year":"2012","journal-title":"J. Biol. Chem."},{"issue":"7201","key":"10.1016\/j.lfs.2023.121943_bb0660","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/nature07006","article-title":"Essential role for nix in autophagic maturation of erythroid cells","volume":"454","author":"Sandoval","year":"2008","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.lfs.2023.121943_bb0665","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/ncb2422","article-title":"Mitochondrial outer-membrane protein FUNDC1 mediates hypoxia-induced mitophagy in mammalian cells","volume":"14","author":"Liu","year":"2012","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.lfs.2023.121943_bb0670","doi-asserted-by":"crossref","first-page":"7527","DOI":"10.1038\/ncomms8527","article-title":"Bcl-2-like protein 13 is a mammalian Atg32 homologue that mediates mitophagy and mitochondrial fragmentation","volume":"6","author":"Murakawa","year":"2015","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.lfs.2023.121943_bb0675","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1002\/hep.27420","article-title":"ALCAT1 controls mitochondrial etiology of fatty liver diseases, linking defective mitophagy to steatosis","volume":"61","author":"Wang","year":"2015","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.lfs.2023.121943_bb0680","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.cmet.2018.06.014","article-title":"Mitochondrial stasis reveals p62-mediated ubiquitination in parkin-independent mitophagy and mitigates nonalcoholic fatty liver disease","volume":"28","author":"Yamada","year":"2018","journal-title":"Cell Metab."},{"key":"10.1016\/j.lfs.2023.121943_bb0685","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2019.101120","article-title":"Mst1 inhibition attenuates non-alcoholic fatty liver disease via reversing Parkin-related mitophagy","volume":"21","author":"Zhou","year":"2019","journal-title":"Redox Biol."},{"key":"10.1016\/j.lfs.2023.121943_bb0690","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.cca.2020.02.024","article-title":"Bnip3 in mitophagy: novel insights and potential therapeutic target for diseases of secondary mitochondrial dysfunction","volume":"506","author":"Gao","year":"2020","journal-title":"Clin. Chim. Acta"},{"issue":"5","key":"10.1016\/j.lfs.2023.121943_bb0695","first-page":"190","article-title":"Role of mitochondrial depolarization and disrupted mitochondrial homeostasis in non-alcoholic steatohepatitis and fibrosis in mice","volume":"11","author":"Krishnasamy","year":"2019","journal-title":"Int. J. Physiol. Pathophysiol. Pharmacol."},{"issue":"15","key":"10.1016\/j.lfs.2023.121943_bb0700","doi-asserted-by":"crossref","first-page":"3591","DOI":"10.1111\/bph.15083","article-title":"Cyanidin-3-O-glucoside improves non-alcoholic fatty liver disease by promoting PINK1-mediated mitophagy in mice","volume":"177","author":"Li","year":"2020","journal-title":"Br. J. Pharmacol."},{"issue":"16","key":"10.1016\/j.lfs.2023.121943_bb0705","doi-asserted-by":"crossref","DOI":"10.1002\/mnfr.201800164","article-title":"Frataxin-mediated PINK1-parkin-dependent mitophagy in hepatic steatosis: the protective effects of quercetin","volume":"62","author":"Liu","year":"2018","journal-title":"Mol. Nutr. Food Res."},{"issue":"5","key":"10.1016\/j.lfs.2023.121943_bb0710","doi-asserted-by":"crossref","DOI":"10.3390\/antiox11050893","article-title":"Hydroxytyrosol promotes the mitochondrial function through activating mitophagy","volume":"11","author":"Dong","year":"2022","journal-title":"Antioxidants"},{"key":"10.1016\/j.lfs.2023.121943_bb0715","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2019.101205","article-title":"Vinyl chloride-induced interaction of nonalcoholic and toxicant-associated steatohepatitis: protection by the ALDH2 activator Alda-1","volume":"24","author":"Chen","year":"2019","journal-title":"Redox Biol."},{"issue":"15","key":"10.1016\/j.lfs.2023.121943_bb0720","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23158267","article-title":"COX-2\/sEH dual inhibitor alleviates hepatocyte senescence in NAFLD mice by restoring autophagy through Sirt1\/PI3K\/AKT\/mTOR","volume":"23","author":"Zhang","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.lfs.2023.121943_bb0725","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.redox.2018.07.011","article-title":"Therapeutic effect of Sirtuin 3 on ameliorating nonalcoholic fatty liver disease: the role of the ERK-CREB pathway and Bnip3-mediated mitophagy","volume":"18","author":"Li","year":"2018","journal-title":"Redox Biol."},{"key":"10.1016\/j.lfs.2023.121943_bb0730","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2019.172715","article-title":"Liraglutide ameliorates non-alcoholic steatohepatitis by inhibiting NLRP3 inflammasome and pyroptosis activation via mitophagy","volume":"864","author":"Yu","year":"2019","journal-title":"Eur. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.lfs.2023.121943_bb0735","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.jphs.2017.11.007","article-title":"Akebia saponin D alleviates hepatic steatosis through BNip3 induced mitophagy","volume":"136","author":"Gong","year":"2018","journal-title":"J. Pharmacol. Sci."},{"issue":"5","key":"10.1016\/j.lfs.2023.121943_bb0740","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1002\/mnfr.201300186","article-title":"Wolfberries potentiate mitophagy and enhance mitochondrial biogenesis leading to prevention of hepatic steatosis in obese mice: the role of AMP-activated protein kinase \u03b12 subunit","volume":"58","author":"Lin","year":"2014","journal-title":"Mol. Nutr. Food Res."},{"issue":"3","key":"10.1016\/j.lfs.2023.121943_bb0745","doi-asserted-by":"crossref","DOI":"10.3390\/cells10030657","article-title":"The MAMs structure and its role in cell death","volume":"10","author":"Wang","year":"2021","journal-title":"Cells"},{"issue":"9","key":"10.1016\/j.lfs.2023.121943_bb0750","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1038\/cdd.2016.52","article-title":"The coming of age of the mitochondria-ER contact: a matter of thickness","volume":"23","author":"Giacomello","year":"2016","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.lfs.2023.121943_bb0755","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.jprot.2012.12.018","article-title":"In-depth proteomic analysis of mammalian mitochondria-associated membranes (MAM)","volume":"79","author":"Poston","year":"2013","journal-title":"J. Proteome"},{"issue":"10","key":"10.1016\/j.lfs.2023.121943_bb0760","doi-asserted-by":"crossref","DOI":"10.1074\/mcp.M111.009936","article-title":"Quantitative proteomic analyses of human cytomegalovirus-induced restructuring of endoplasmic reticulum-mitochondrial contacts at late times of infection","volume":"10","author":"Zhang","year":"2011","journal-title":"Mol. Cell. Proteomics"},{"issue":"23","key":"10.1016\/j.lfs.2023.121943_bb0765","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1161\/CIRCULATIONAHA.117.030235","article-title":"Binding of FUN14 domain containing 1 with inositol 1,4,5-trisphosphate receptor in mitochondria-associated endoplasmic reticulum membranes maintains mitochondrial dynamics and function in hearts in vivo","volume":"136","author":"Wu","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.lfs.2023.121943_bb0770","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2020.104741","article-title":"Mitochondrial fission in Huntington\u2019s disease mouse striatum disrupts ER-mitochondria contacts leading to disturbances in Ca(2+) efflux and reactive oxygen species (ROS) homeostasis","volume":"136","author":"Cherubini","year":"2020","journal-title":"Neurobiol. Dis."},{"issue":"50","key":"10.1016\/j.lfs.2023.121943_bb0775","doi-asserted-by":"crossref","first-page":"25322","DOI":"10.1073\/pnas.1906565116","article-title":"DJ-1 regulates the integrity and function of ER-mitochondria association through interaction with IP3R3-Grp75-VDAC1","volume":"116","author":"Liu","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.lfs.2023.121943_bb0780","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.expneurol.2018.07.018","article-title":"Mutation of hop-1 and pink-1 attenuates vulnerability of neurotoxicity in C. elegans: the role of mitochondria-associated membrane proteins in Parkinsonism","volume":"309","author":"Wu","year":"2018","journal-title":"Exp. Neurol."},{"issue":"13","key":"10.1016\/j.lfs.2023.121943_bb0785","doi-asserted-by":"crossref","first-page":"3573","DOI":"10.1016\/j.celrep.2018.11.094","article-title":"Transglutaminase type 2 regulates ER-mitochondria contact sites by interacting with GRP75","volume":"25","author":"D\u2019Eletto","year":"2018","journal-title":"Cell Rep."},{"issue":"12","key":"10.1016\/j.lfs.2023.121943_bb0790","doi-asserted-by":"crossref","first-page":"6625","DOI":"10.1007\/s12035-021-02488-6","article-title":"Sigma-1 receptor activation suppresses microglia M1 polarization via regulating endoplasmic reticulum-mitochondria contact and mitochondrial functions in stress-induced hypertension rats","volume":"58","author":"Ooi","year":"2021","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.lfs.2023.121943_bb0795","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.796061","article-title":"Evaluation of parkin in the regulation of myocardial mitochondria-associated membranes and cardiomyopathy during endotoxemia","volume":"10","author":"Kim","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"issue":"14","key":"10.1016\/j.lfs.2023.121943_bb0800","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1161\/CIRCULATIONAHA.113.001225","article-title":"Depressing mitochondria-reticulum interactions protects cardiomyocytes from lethal hypoxia-reoxygenation injury","volume":"128","author":"Paillard","year":"2013","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.lfs.2023.121943_bb0805","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/sj.emboj.7600559","article-title":"PACS-2 controls endoplasmic reticulum-mitochondria communication and Bid-mediated apoptosis","volume":"24","author":"Simmen","year":"2005","journal-title":"EMBO J."},{"issue":"5","key":"10.1016\/j.lfs.2023.121943_bb0810","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1007\/s12192-010-0174-1","article-title":"Ero1alpha requires oxidizing and normoxic conditions to localize to the mitochondria-associated membrane (MAM)","volume":"15","author":"Gilady","year":"2010","journal-title":"Cell Stress Chaperones"},{"key":"10.1016\/j.lfs.2023.121943_bb0815","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2022.115011","article-title":"Potential role of mitochondria-associated endoplasmic reticulum membrane proteins in diseases","volume":"199","author":"Mao","year":"2022","journal-title":"Biochem. Pharmacol."},{"issue":"10\u201312","key":"10.1016\/j.lfs.2023.121943_bb0820","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1089\/ars.2020.8231","article-title":"Endoplasmic reticulum-mitochondria contacts modulate reactive oxygen species-mediated signaling and oxidative stress in brain disorders: the key role of sigma-1 receptor","volume":"37","author":"Resende","year":"2022","journal-title":"Antioxid. Redox Signal."},{"issue":"12","key":"10.1016\/j.lfs.2023.121943_bb0825","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1038\/nm.3735","article-title":"Chronic enrichment of hepatic endoplasmic reticulum-mitochondria contact leads to mitochondrial dysfunction in obesity","volume":"20","author":"Arruda","year":"2014","journal-title":"Nat. Med."},{"issue":"11","key":"10.1016\/j.lfs.2023.121943_bb0830","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.1111\/bph.15767","article-title":"Ruthenium 360 and mitoxantrone inhibit mitochondrial calcium uniporter channel to prevent liver steatosis induced by high-fat diet","volume":"179","author":"Zhang","year":"2022","journal-title":"Br. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.lfs.2023.121943_bb0835","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s12944-020-01210-0","article-title":"Mutual interaction between endoplasmic reticulum and mitochondria in nonalcoholic fatty liver disease","volume":"19","author":"Wang","year":"2020","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.lfs.2023.121943_bb0840","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2020.101678","article-title":"Interrelation between ROS and Ca(2+) in aging and age-related diseases","volume":"36","author":"Madreiter-Sokolowski","year":"2020","journal-title":"Redox Biol."},{"issue":"1","key":"10.1016\/j.lfs.2023.121943_bb0845","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s12944-023-01798-z","article-title":"Exercise activates Sirt1-mediated Drp1 acetylation and inhibits hepatocyte apoptosis to improve nonalcoholic fatty liver disease","volume":"22","author":"Hu","year":"2023","journal-title":"Lipids Health Dis."},{"issue":"12","key":"10.1016\/j.lfs.2023.121943_bb0850","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1136\/gutjnl-2021-325013","article-title":"NFATc1 signaling drives chronic ER stress responses to promote NAFLD progression","volume":"71","author":"Latif","year":"2022","journal-title":"Gut"},{"issue":"4","key":"10.1016\/j.lfs.2023.121943_bb0855","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/j.jhep.2011.10.018","article-title":"Accumulation of endoplasmic reticulum stress and lipogenesis in the liver through generational effects of high fat diets","volume":"56","author":"Li","year":"2012","journal-title":"J. Hepatol."},{"issue":"10","key":"10.1016\/j.lfs.2023.121943_bb0860","doi-asserted-by":"crossref","first-page":"3279","DOI":"10.2337\/db13-1751","article-title":"Mitochondria-associated endoplasmic reticulum membrane (MAM) integrity is required for insulin signaling and is implicated in hepatic insulin resistance","volume":"63","author":"Tubbs","year":"2014","journal-title":"Diabetes"},{"issue":"3","key":"10.1016\/j.lfs.2023.121943_bb0865","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.jhep.2022.03.017","article-title":"Endoplasmic reticulum-mitochondria miscommunication is an early and causal trigger of hepatic insulin resistance and steatosis","volume":"77","author":"Beaulant","year":"2022","journal-title":"J. Hepatol."},{"issue":"3","key":"10.1016\/j.lfs.2023.121943_bb0870","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.scib.2021.10.014","article-title":"Hepatic CDP-diacylglycerol synthase 2 deficiency causes mitochondrial dysfunction and promotes rapid progression of NASH and fibrosis","volume":"67","author":"Xu","year":"2022","journal-title":"Sci. Bull."},{"issue":"14","key":"10.1016\/j.lfs.2023.121943_bb0875","doi-asserted-by":"crossref","first-page":"3745","DOI":"10.7150\/ijbs.57610","article-title":"Lipotoxic hepatocytes promote nonalcoholic fatty liver disease progression by delivering microRNA-9-5p and activating macrophages","volume":"17","author":"Liu","year":"2021","journal-title":"Int. J. Biol. Sci."},{"issue":"5","key":"10.1016\/j.lfs.2023.121943_bb0880","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1053\/j.gastro.2005.02.001","article-title":"Mice heterozygous for a defect in mitochondrial trifunctional protein develop hepatic steatosis and insulin resistance","volume":"128","author":"Ibdah","year":"2005","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.lfs.2023.121943_bb0885","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1002\/hep.26285","article-title":"Selective hepatic insulin resistance in a murine model heterozygous for a mitochondrial trifunctional protein defect","volume":"57","author":"Rector","year":"2013","journal-title":"Hepatology"},{"issue":"43","key":"10.1016\/j.lfs.2023.121943_bb0890","doi-asserted-by":"crossref","first-page":"17075","DOI":"10.1073\/pnas.0707060104","article-title":"Mitochondrial dysfunction due to long-chain acyl-CoA dehydrogenase deficiency causes hepatic steatosis and hepatic insulin resistance","volume":"104","author":"Zhang","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"10","key":"10.1016\/j.lfs.2023.121943_bb0895","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22105375","article-title":"Nonalcoholic fatty liver disease (NAFLD). Mitochondria as players and targets of therapies?","volume":"22","author":"Di Ciaula","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.lfs.2023.121943_bb0900","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10020274","article-title":"Pharmacotherapy for non-alcoholic fatty liver disease: emerging targets and drug candidates","volume":"10","author":"Prikhodko","year":"2022","journal-title":"Biomedicines"},{"issue":"1","key":"10.1016\/j.lfs.2023.121943_bb0905","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/cts.12839","article-title":"Evolving role for pharmacotherapy in NAFLD\/NASH","volume":"14","author":"Attia","year":"2021","journal-title":"Clin. Transl. Sci."},{"issue":"35","key":"10.1016\/j.lfs.2023.121943_bb0910","doi-asserted-by":"crossref","first-page":"5129","DOI":"10.3748\/wjg.v28.i35.5129","article-title":"Combination strategies for pharmacologic treatment of non-alcoholic steatohepatitis","volume":"28","author":"Suri","year":"2022","journal-title":"World J. Gastroenterol."},{"issue":"8","key":"10.1016\/j.lfs.2023.121943_bb0915","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1016\/j.cgh.2023.03.041","article-title":"Clinical trial landscape in NASH","volume":"21","author":"Harrison","year":"2023","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.lfs.2023.121943_bb0920","first-page":"25","article-title":"Systematic review of existing guidelines for NAFLD assessment","volume":"7","author":"Monelli","year":"2021","journal-title":"Hepatoma Res."},{"issue":"10","key":"10.1016\/j.lfs.2023.121943_bb0925","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1080\/14656566.2021.1912014","article-title":"What considerations are there for the pharmacotherapeutic management of nonalcoholic steatohepatitis?","volume":"22","author":"Yoneda","year":"2021","journal-title":"Expert. Opin. Pharmacother."},{"issue":"5","key":"10.1016\/j.lfs.2023.121943_bb0930","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1007\/s10620-016-4054-0","article-title":"Role of dietary fructose and hepatic de novo lipogenesis in fatty liver disease","volume":"61","author":"Softic","year":"2016","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.lfs.2023.121943_bb0935","article-title":"Gut microbiota-mitochondrial inter-talk in non-alcoholic fatty liver disease","volume":"9","author":"Zhang","year":"2022","journal-title":"Front. Nutr."},{"key":"10.1016\/j.lfs.2023.121943_bb0940","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.796207","article-title":"Mitochondrial targeting therapeutics: promising role of natural products in non-alcoholic fatty liver disease","volume":"12","author":"Xu","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"4","key":"10.1016\/j.lfs.2023.121943_bb0945","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.jhep.2017.05.016","article-title":"Treatment of NAFLD with diet, physical activity and exercise","volume":"67","author":"Romero-G\u00f3mez","year":"2017","journal-title":"J. Hepatol."},{"issue":"5","key":"10.1016\/j.lfs.2023.121943_bb0950","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.gastrohep.2017.12.003","article-title":"Consensus document. Management of non-alcoholic fatty liver disease (NAFLD). Clinical practice guideline","volume":"41","author":"Aller","year":"2018","journal-title":"Gastroenterol. Hepatol."},{"issue":"2","key":"10.1016\/j.lfs.2023.121943_bb0955","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3727\/105221617X15124844266408","article-title":"The effects of physical exercise on fatty liver disease","volume":"18","author":"van der Windt","year":"2018","journal-title":"Gene Expr."},{"issue":"1","key":"10.1016\/j.lfs.2023.121943_bb0960","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jhep.2012.02.023","article-title":"Exercise and non-alcoholic fatty liver disease: a systematic review and meta-analysis","volume":"57","author":"Keating","year":"2012","journal-title":"J. Hepatol."},{"issue":"4","key":"10.1016\/j.lfs.2023.121943_bb0965","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/j.jhep.2011.08.018","article-title":"Omega-3 supplementation and non-alcoholic fatty liver disease: a systematic review and meta-analysis","volume":"56","author":"Parker","year":"2012","journal-title":"J. Hepatol."},{"issue":"3","key":"10.1016\/j.lfs.2023.121943_bb0970","doi-asserted-by":"crossref","DOI":"10.1111\/eci.13731","article-title":"The advantages of physical exercise as a preventive strategy against NAFLD in postmenopausal women","volume":"52","author":"Molina-Molina","year":"2022","journal-title":"Eur. J. Clin. Investig."},{"issue":"2","key":"10.1016\/j.lfs.2023.121943_bb0975","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1002\/hep.22350","article-title":"Visceral fat: a key mediator of steatohepatitis in metabolic liver disease","volume":"48","author":"van der Poorten","year":"2008","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.lfs.2023.121943_bb0980","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1113\/JP278853","article-title":"Exercise and mitochondrial health","volume":"599","author":"Memme","year":"2021","journal-title":"J. Physiol."},{"key":"10.1016\/j.lfs.2023.121943_bb0985","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.molmet.2019.11.015","article-title":"Physical exercise and liver \u201cfitness\u201d: role of mitochondrial function and epigenetics-related mechanisms in non-alcoholic fatty liver disease","volume":"32","author":"Stevanovi\u0107","year":"2020","journal-title":"Mol. Metab."},{"key":"10.1016\/j.lfs.2023.121943_bb0990","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.mito.2014.03.012","article-title":"Physical exercise prevents and mitigates non-alcoholic steatohepatitis-induced liver mitochondrial structural and bioenergetics impairments","volume":"15","author":"Gon\u00e7alves","year":"2014","journal-title":"Mitochondrion"},{"key":"10.1016\/j.lfs.2023.121943_bb0995","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.biocel.2014.07.011","article-title":"Exercise alters liver mitochondria phospholipidomic profile and mitochondrial activity in non-alcoholic steatohepatitis","volume":"54","author":"Gon\u00e7alves","year":"2014","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"1\u20132","key":"10.1016\/j.lfs.2023.121943_bb1000","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.lfs.2009.11.003","article-title":"Endurance exercise causes mitochondrial and oxidative stress in rat liver: effects of a combination of mitochondrial targeting nutrients","volume":"86","author":"Sun","year":"2010","journal-title":"Life Sci."},{"issue":"2","key":"10.1016\/j.lfs.2023.121943_bb1005","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0055668","article-title":"Swimming training induces liver mitochondrial adaptations to oxidative stress in rats submitted to repeated exhaustive swimming bouts","volume":"8","author":"Lima","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.lfs.2023.121943_bb1010","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/9233650","article-title":"A molecular insight into the role of antioxidants in nonalcoholic fatty liver diseases","volume":"2022","author":"Ezhilarasan","year":"2022","journal-title":"Oxidative Med. Cell. Longev."},{"issue":"18","key":"10.1016\/j.lfs.2023.121943_bb1015","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1056\/NEJMoa0907929","article-title":"Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis","volume":"362","author":"Sanyal","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.lfs.2023.121943_bb1020","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2021.745609","article-title":"Effects of oral vitamin C supplementation on liver health and associated parameters in patients with non-alcoholic fatty liver disease: a randomized clinical trial","volume":"8","author":"He","year":"2021","journal-title":"Front. Nutr."},{"issue":"2","key":"10.1016\/j.lfs.2023.121943_bb1025","doi-asserted-by":"crossref","first-page":"569","DOI":"10.3748\/wjg.v20.i2.569","article-title":"Effects of pentoxifylline on nonalcoholic fatty liver disease: a meta-analysis","volume":"20","author":"Du","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.lfs.2023.121943_bb1030","doi-asserted-by":"crossref","DOI":"10.1016\/j.nut.2020.111092","article-title":"Impact of Silymarin in individuals with nonalcoholic fatty liver disease: a systematic review and meta-analysis","volume":"83","author":"Kalopitas","year":"2021","journal-title":"Nutrition"},{"issue":"1","key":"10.1016\/j.lfs.2023.121943_bb1035","doi-asserted-by":"crossref","first-page":"59","DOI":"10.15403\/jgld.2014.1121.261.ely","article-title":"Resveratrol supplementation in patients with non-alcoholic fatty liver disease: systematic review and meta-analysis","volume":"26","author":"Elgebaly","year":"2017","journal-title":"J. Gastrointest. Liver Dis."},{"key":"10.1016\/j.lfs.2023.121943_bb1040","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctcp.2020.101281","article-title":"Efficacy of resveratrol supplementation in patients with nonalcoholic fatty liver disease: a systematic review and meta-analysis of clinical trials","volume":"42","author":"Rafiee","year":"2021","journal-title":"Complement. Ther. Clin. Pract."},{"issue":"6","key":"10.1016\/j.lfs.2023.121943_bb1045","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.apsb.2018.05.006","article-title":"Mitochondria-targeting drug conjugates for cytotoxic, anti-oxidizing and sensing purposes: current strategies and future perspectives","volume":"8","author":"Battogtokh","year":"2018","journal-title":"Acta Pharm. Sin. B"},{"issue":"7","key":"10.1016\/j.lfs.2023.121943_bb1050","doi-asserted-by":"crossref","first-page":"4588","DOI":"10.1074\/jbc.M009093200","article-title":"Selective targeting of a redox-active ubiquinone to mitochondria within cells: antioxidant and antiapoptotic properties","volume":"276","author":"Kelso","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"22","key":"10.1016\/j.lfs.2023.121943_bb1055","doi-asserted-by":"crossref","first-page":"21295","DOI":"10.1074\/jbc.M501527200","article-title":"Interactions of mitochondria-targeted and untargeted ubiquinones with the mitochondrial respiratory chain and reactive oxygen species. Implications for the use of exogenous ubiquinones as therapies and experimental tools","volume":"280","author":"James","year":"2005","journal-title":"J. Biol. Chem."},{"issue":"22","key":"10.1016\/j.lfs.2023.121943_bb1060","doi-asserted-by":"crossref","first-page":"3857","DOI":"10.1080\/10408398.2020.1809344","article-title":"Protective role of mitoquinone against impaired mitochondrial homeostasis in metabolic syndrome","volume":"61","author":"Yang","year":"2021","journal-title":"Crit. Rev. Food Sci. Nutr."},{"issue":"10","key":"10.1016\/j.lfs.2023.121943_bb1065","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.3109\/10715762.2014.945079","article-title":"The mitochondrial-targeted antioxidant MitoQ ameliorates metabolic syndrome features in obesogenic diet-fed rats better than Apocynin or Allopurinol","volume":"48","author":"Feillet-Coudray","year":"2014","journal-title":"Free Radic. Res."},{"issue":"10","key":"10.1016\/j.lfs.2023.121943_bb1070","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/j.bbabio.2015.05.019","article-title":"The mitochondrial-targeted antioxidant, MitoQ, increases liver mitochondrial cardiolipin content in obesogenic diet-fed rats","volume":"1847","author":"Fouret","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"issue":"5","key":"10.1016\/j.lfs.2023.121943_bb1075","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.freeradbiomed.2011.11.026","article-title":"The mitochondria-targeted antioxidant MitoQ decreases features of the metabolic syndrome in ATM+\/\u2212\/ApoE\u2212\/\u2212 mice","volume":"52","author":"Mercer","year":"2012","journal-title":"Free Radic. Biol. Med."},{"issue":"7","key":"10.1016\/j.lfs.2023.121943_bb1080","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1111\/j.1478-3231.2010.02250.x","article-title":"The mitochondria-targeted anti-oxidant mitoquinone decreases liver damage in a phase II study of hepatitis C patients","volume":"30","author":"Gane","year":"2010","journal-title":"Liver Int."},{"issue":"2","key":"10.1016\/j.lfs.2023.121943_bb1085","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.bbadis.2005.10.007","article-title":"Targeting antioxidants to mitochondria: a new therapeutic direction","volume":"1762","author":"Sheu","year":"2006","journal-title":"Biochim. Biophys. Acta"},{"issue":"13","key":"10.1016\/j.lfs.2023.121943_bb1090","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1096\/fj.03-0240fje","article-title":"Mitochondria-targeted antioxidants protect Friedreich ataxia fibroblasts from endogenous oxidative stress more effectively than untargeted antioxidants","volume":"17","author":"Jauslin","year":"2003","journal-title":"FASEB J."},{"issue":"8","key":"10.1016\/j.lfs.2023.121943_bb1095","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.3945\/jn.110.121715","article-title":"A mitochondria-targeted vitamin E derivative decreases hepatic oxidative stress and inhibits fat deposition in mice","volume":"140","author":"Mao","year":"2010","journal-title":"J. Nutr."},{"issue":"7","key":"10.1016\/j.lfs.2023.121943_bb1100","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1016\/j.freeradbiomed.2007.12.036","article-title":"A mitochondria-targeted nitroxide is reduced to its hydroxylamine by ubiquinol in mitochondria","volume":"44","author":"Trnka","year":"2008","journal-title":"Free Radic. Biol. Med."},{"issue":"5","key":"10.1016\/j.lfs.2023.121943_bb1105","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.115.003046","article-title":"Role of mitochondrial oxidative stress in glucose tolerance, insulin resistance, and cardiac diastolic dysfunction","volume":"5","author":"Jeong","year":"2016","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.lfs.2023.121943_bb1110","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/9329427","article-title":"Protective effects of MitoTEMPO on nonalcoholic fatty liver disease via regulating myeloid-derived suppressor cells and inflammation in mice","volume":"2020","author":"Wu","year":"2020","journal-title":"Biomed. Res. Int."},{"issue":"7593","key":"10.1016\/j.lfs.2023.121943_bb1115","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/nature16969","article-title":"NAFLD causes selective CD4(+) T lymphocyte loss and promotes hepatocarcinogenesis","volume":"531","author":"Ma","year":"2016","journal-title":"Nature"},{"issue":"33","key":"10.1016\/j.lfs.2023.121943_bb1120","doi-asserted-by":"crossref","first-page":"34682","DOI":"10.1074\/jbc.M402999200","article-title":"Cell-permeable peptide antioxidants targeted to inner mitochondrial membrane inhibit mitochondrial swelling, oxidative cell death, and reperfusion injury","volume":"279","author":"Zhao","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"8","key":"10.1016\/j.lfs.2023.121943_bb1125","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1111\/bph.12461","article-title":"First-in-class cardiolipin-protective compound as a therapeutic agent to restore mitochondrial bioenergetics","volume":"171","author":"Szeto","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.lfs.2023.121943_bb1130","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.mito.2021.02.007","article-title":"Protective effects of a mitochondria-targeted small peptide SS31 against hyperglycemia-induced mitochondrial abnormalities in the liver tissues of diabetic mice, Tallyho\/JngJ mice","volume":"58","author":"Bhatti","year":"2021","journal-title":"Mitochondrion"},{"issue":"3","key":"10.1016\/j.lfs.2023.121943_bb1135","first-page":"C692","article-title":"Contribution of mitochondrial proton leak to respiration rate in working skeletal muscle and liver and to SMR","volume":"276","author":"Rolfe","year":"1999","journal-title":"Am. J. Phys."},{"issue":"8","key":"10.1016\/j.lfs.2023.121943_bb1140","doi-asserted-by":"crossref","DOI":"10.3390\/cells8080795","article-title":"Mitochondrial uncoupling: a key controller of biological processes in physiology and diseases","volume":"8","author":"Demine","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.lfs.2023.121943_bb1145","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2021.101178","article-title":"Therapeutic potential of mitochondrial uncouplers for the treatment of metabolic associated fatty liver disease and NASH","volume":"46","author":"Goedeke","year":"2021","journal-title":"Mol. Metab."},{"issue":"1","key":"10.1016\/j.lfs.2023.121943_bb1150","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/hep.29086","article-title":"AASLD guidelines for the treatment of hepatocellular carcinoma","volume":"67","author":"Heimbach","year":"2018","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.lfs.2023.121943_bb1155","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.cmet.2020.04.011","article-title":"Low-dose sorafenib acts as a mitochondrial uncoupler and ameliorates nonalcoholic steatohepatitis","volume":"31","author":"Jian","year":"2020","journal-title":"Cell Metab."},{"issue":"6","key":"10.1016\/j.lfs.2023.121943_bb1160","doi-asserted-by":"crossref","first-page":"346","DOI":"10.7326\/0003-4819-152-6-201003160-00004","article-title":"The effects of salsalate on glycemic control in patients with type 2 diabetes: a randomized trial","volume":"152","author":"Goldfine","year":"2010","journal-title":"Ann. Intern. Med."},{"issue":"7\u20138","key":"10.1016\/j.lfs.2023.121943_bb1165","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1345\/aph.1M483","article-title":"Potential role of salicylates in type 2 diabetes","volume":"44","author":"Rumore","year":"2010","journal-title":"Ann. Pharmacother."},{"issue":"12","key":"10.1016\/j.lfs.2023.121943_bb1170","doi-asserted-by":"crossref","first-page":"4132","DOI":"10.2337\/dc13-0859","article-title":"Targeting inflammation using salsalate in patients with type 2 diabetes: effects on flow-mediated dilation (TINSAL-FMD)","volume":"36","author":"Goldfine","year":"2013","journal-title":"Diabetes Care"},{"issue":"22","key":"10.1016\/j.lfs.2023.121943_bb1175","doi-asserted-by":"crossref","first-page":"5293","DOI":"10.1111\/bph.13315","article-title":"Salsalate attenuates diet induced non-alcoholic steatohepatitis in mice by decreasing lipogenic and inflammatory processes","volume":"172","author":"Liang","year":"2015","journal-title":"Br. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.lfs.2023.121943_bb1180","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1111\/bcpt.13535","article-title":"Salsalate reverses metabolic disorders in a mouse model of non-alcoholic fatty liver disease through AMPK activation and caspase-6 activity inhibition","volume":"128","author":"Li","year":"2021","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"issue":"11","key":"10.1016\/j.lfs.2023.121943_bb1185","doi-asserted-by":"crossref","first-page":"3352","DOI":"10.2337\/db16-0564","article-title":"Salsalate (salicylate) uncouples mitochondria, improves glucose homeostasis, and reduces liver lipids independent of AMPK-\u03b21","volume":"65","author":"Smith","year":"2016","journal-title":"Diabetes"},{"key":"10.1016\/j.lfs.2023.121943_bb1190","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.ebiom.2017.08.004","article-title":"Salsalate activates skeletal muscle thermogenesis and protects mice from high-fat diet induced metabolic dysfunction","volume":"23","author":"Nie","year":"2017","journal-title":"EBioMedicine"},{"issue":"5185","key":"10.1016\/j.lfs.2023.121943_bb1195","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1038\/2211016a0","article-title":"Mechanism of action of reagents that uncouple oxidative phosphorylation","volume":"221","author":"Weinbach","year":"1969","journal-title":"Nature"},{"key":"10.1016\/j.lfs.2023.121943_bb1200","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.cellsig.2017.04.001","article-title":"Niclosamide: beyond an antihelminthic drug","volume":"41","author":"Chen","year":"2018","journal-title":"Cell. Signal."},{"issue":"3809","key":"10.1016\/j.lfs.2023.121943_bb1205","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1126\/science.158.3809.1694","article-title":"Salicylanilides: a new group of active uncouplers of oxidative phosphorylation","volume":"158","author":"Williamson","year":"1967","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.lfs.2023.121943_bb1210","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/0163-7258(82)90064-X","article-title":"The biology and toxicology of molluscicides, Bayluscide","volume":"19","author":"Andrews","year":"1982","journal-title":"Pharmacol. Ther."},{"issue":"11","key":"10.1016\/j.lfs.2023.121943_bb1215","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1038\/nm.3699","article-title":"Niclosamide ethanolamine-induced mild mitochondrial uncoupling improves diabetic symptoms in mice","volume":"20","author":"Tao","year":"2014","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.lfs.2023.121943_bb1220","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s40519-017-0424-7","article-title":"Niclosamide piperazine prevents high-fat diet-induced obesity and diabetic symptoms in mice","volume":"24","author":"Guo","year":"2019","journal-title":"Eat. Weight Disord."},{"issue":"38","key":"10.1016\/j.lfs.2023.121943_bb1225","doi-asserted-by":"crossref","first-page":"15731","DOI":"10.1074\/jbc.M117.791863","article-title":"The unintended mitochondrial uncoupling effects of the FDA-approved anti-helminth drug nitazoxanide mitigates experimental parkinsonism in mice","volume":"292","author":"Amireddy","year":"2017","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.lfs.2023.121943_bb1230","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1016\/j.apsb.2021.09.009","article-title":"Anthelmintics nitazoxanide protects against experimental hyperlipidemia and hepatic steatosis in hamsters and mice","volume":"12","author":"Li","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"issue":"6090","key":"10.1016\/j.lfs.2023.121943_bb1235","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1126\/science.1218530","article-title":"Identification and functional expression of the mitochondrial pyruvate carrier","volume":"337","author":"Herzig","year":"2012","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.lfs.2023.121943_bb1240","doi-asserted-by":"crossref","DOI":"10.3390\/biom13020261","article-title":"The hepatic mitochondrial pyruvate carrier as a regulator of systemic metabolism and a therapeutic target for treating metabolic disease","volume":"13","author":"McCommis","year":"2023","journal-title":"Biomolecules"},{"issue":"15","key":"10.1016\/j.lfs.2023.121943_bb1245","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1128\/MCB.00166-16","article-title":"Requirement for the mitochondrial pyruvate carrier in mammalian development revealed by a hypomorphic allelic series","volume":"36","author":"Bowman","year":"2016","journal-title":"Mol. Cell. Biol."},{"issue":"4","key":"10.1016\/j.lfs.2023.121943_bb1250","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.cmet.2015.07.028","article-title":"Loss of mitochondrial pyruvate carrier 2 in the liver leads to defects in gluconeogenesis and compensation via pyruvate-alanine cycling","volume":"22","author":"McCommis","year":"2015","journal-title":"Cell Metab."},{"issue":"2","key":"10.1016\/j.lfs.2023.121943_bb1255","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.jcmgh.2018.09.017","article-title":"Treating hepatic steatosis and fibrosis by modulating mitochondrial pyruvate metabolism","volume":"7","author":"McCommis","year":"2019","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"issue":"4","key":"10.1016\/j.lfs.2023.121943_bb1260","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.jhep.2019.10.023","article-title":"Insulin sensitizer MSDC-0602K in non-alcoholic steatohepatitis: a randomized, double-blind, placebo-controlled phase IIb study","volume":"72","author":"Harrison","year":"2020","journal-title":"J. Hepatol."},{"issue":"5","key":"10.1016\/j.lfs.2023.121943_bb1265","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1002\/hep.29025","article-title":"Targeting the mitochondrial pyruvate carrier attenuates fibrosis in a mouse model of nonalcoholic steatohepatitis","volume":"65","author":"McCommis","year":"2017","journal-title":"Hepatology"},{"issue":"7","key":"10.1016\/j.lfs.2023.121943_bb1270","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1080\/13543784.2018.1494153","article-title":"MSDC-0602K, a metabolic modulator directed at the core pathology of non-alcoholic steatohepatitis","volume":"27","author":"Colca","year":"2018","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.lfs.2023.121943_bb1275","doi-asserted-by":"crossref","DOI":"10.1097\/HEP.0000000000000279","article-title":"Mitochondrial pyruvate carrier 1 regulates fatty acid synthase lactylation and mediates treatment of nonalcoholic fatty liver disease","author":"Gao","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.lfs.2023.121943_bb1280","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2023.101694","article-title":"Mitochondrial pyruvate carrier inhibition initiates metabolic crosstalk to stimulate branched chain amino acid catabolism","volume":"70","author":"Ferguson","year":"2023","journal-title":"Mol. Metab."},{"issue":"8","key":"10.1016\/j.lfs.2023.121943_bb1285","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1002\/hep4.1723","article-title":"Deuterium-stabilized (R)-pioglitazone (PXL065) is responsible for pioglitazone efficacy in NASH yet exhibits little to no PPAR\u03b3 activity","volume":"5","author":"Jacques","year":"2021","journal-title":"Hepatol. Commun."},{"issue":"5","key":"10.1016\/j.lfs.2023.121943_bb1290","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/j.jhep.2023.02.004","article-title":"Evaluation of PXL065 - deuterium-stabilized (R)-pioglitazone in patients with NASH: a phase II randomized placebo-controlled trial (DESTINY-1)","volume":"78","author":"Harrison","year":"2023","journal-title":"J. Hepatol."},{"issue":"9","key":"10.1016\/j.lfs.2023.121943_bb1295","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1002\/term.2914","article-title":"Mesenchymal stem cells: cell therapy and regeneration potential","volume":"13","author":"Brown","year":"2019","journal-title":"J. Tissue Eng. Regen. Med."},{"issue":"1","key":"10.1016\/j.lfs.2023.121943_bb1300","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s13287-018-0816-2","article-title":"A pooled analysis of mesenchymal stem cell-based therapy for liver disease","volume":"9","author":"Zhao","year":"2018","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.lfs.2023.121943_bb1305","doi-asserted-by":"crossref","DOI":"10.1155\/2023\/3919002","article-title":"Mechanisms of action of mesenchymal stem cells in metabolic-associated fatty liver disease","volume":"2023","author":"Yi","year":"2023","journal-title":"Stem Cells Int."},{"key":"10.1016\/j.lfs.2023.121943_bb1310","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3389\/fcell.2016.00107","article-title":"Mitochondria know no boundaries: mechanisms and functions of intercellular mitochondrial transfer","volume":"4","author":"Torralba","year":"2016","journal-title":"Front. Cell Dev. Biol."},{"issue":"5","key":"10.1016\/j.lfs.2023.121943_bb1315","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1073\/pnas.0510511103","article-title":"Mitochondrial transfer between cells can rescue aerobic respiration","volume":"103","author":"Spees","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"9","key":"10.1016\/j.lfs.2023.121943_bb1320","first-page":"994","article-title":"Miro1 regulates intercellular mitochondrial transport & enhances mesenchymal stem cell rescue efficacy","volume":"33","author":"Ahmad","year":"2014","journal-title":"EMBO J."},{"issue":"5","key":"10.1016\/j.lfs.2023.121943_bb1325","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/nm.2736","article-title":"Mitochondrial transfer from bone-marrow-derived stromal cells to pulmonary alveoli protects against acute lung injury","volume":"18","author":"Islam","year":"2012","journal-title":"Nat. Med."},{"issue":"7","key":"10.1016\/j.lfs.2023.121943_bb1330","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.7150\/thno.29400","article-title":"Mitochondrial transfer from bone marrow mesenchymal stem cells to motor neurons in spinal cord injury rats via gap junction","volume":"9","author":"Li","year":"2019","journal-title":"Theranostics"},{"key":"10.1016\/j.lfs.2023.121943_bb1335","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2022.121486","article-title":"Extracellular vesicles derived from mesenchymal stromal cells as nanotherapeutics for liver ischaemia-reperfusion injury by transferring mitochondria to modulate the formation of neutrophil extracellular traps","volume":"284","author":"Lu","year":"2022","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/j.lfs.2023.121943_bb1340","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1186\/s13287-021-02663-5","article-title":"Bone marrow derived-mesenchymal stem cell improves diabetes-associated fatty liver via mitochondria transformation in mice","volume":"12","author":"Bi","year":"2021","journal-title":"Stem Cell Res Ther"},{"issue":"2","key":"10.1016\/j.lfs.2023.121943_bb1345","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1002\/hep.29359","article-title":"The presence and severity of nonalcoholic steatohepatitis is associated with specific changes in circulating bile acids","volume":"67","author":"Puri","year":"2018","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.lfs.2023.121943_bb1350","article-title":"Bile acids contribute to the development of non-alcoholic steatohepatitis in mice","volume":"4","author":"Gillard","year":"2022","journal-title":"JHEP Rep. Innov. Hepatol."},{"issue":"3","key":"10.1016\/j.lfs.2023.121943_bb1355","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.metabol.2010.03.006","article-title":"Plasma metabolomic profile in nonalcoholic fatty liver disease","volume":"60","author":"Kalhan","year":"2011","journal-title":"Metab. Clin. Exp."},{"issue":"11","key":"10.1016\/j.lfs.2023.121943_bb1360","doi-asserted-by":"crossref","first-page":"3318","DOI":"10.1007\/s10620-015-3776-8","article-title":"Altered bile acid metabolome in patients with nonalcoholic steatohepatitis","volume":"60","author":"Ferslew","year":"2015","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.lfs.2023.121943_bb1365","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103290","article-title":"Conjugated secondary 12\u03b1-hydroxylated bile acids promote liver fibrogenesis","volume":"66","author":"Xie","year":"2021","journal-title":"EBioMedicine"},{"issue":"5","key":"10.1016\/j.lfs.2023.121943_bb1370","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1038\/s41401-022-00880-z","article-title":"Bile acid and receptors: biology and drug discovery for nonalcoholic fatty liver disease","volume":"43","author":"Jiao","year":"2022","journal-title":"Acta Pharmacol. Sin."},{"issue":"12","key":"10.1016\/j.lfs.2023.121943_bb1375","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1080\/1744666X.2017.1391093","article-title":"From pathogenesis to novel therapies in the treatment of primary biliary cholangitis","volume":"13","author":"Ronca","year":"2017","journal-title":"Expert. Rev. Clin. Immunol."},{"issue":"12","key":"10.1016\/j.lfs.2023.121943_bb1380","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1042\/CS20110184","article-title":"Ursodeoxycholic acid in cholestasis: linking action mechanisms to therapeutic applications","volume":"121","author":"Roma","year":"2011","journal-title":"Clin. Sci."},{"issue":"11","key":"10.1016\/j.lfs.2023.121943_bb1385","article-title":"Beneficial effects of UDCA and norUDCA in a rodent model of steatosis are linked to modulation of GPBAR1\/FXR signaling","volume":"1867","author":"Marchian\u00f2","year":"2022","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"key":"10.1016\/j.lfs.2023.121943_bb1390","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2022.174760","article-title":"Ursodesoxycholic acid is an FFA4 agonist and reduces hepatic steatosis via FFA4 signaling","volume":"917","author":"Xu","year":"2022","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.lfs.2023.121943_bb1395","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.108938","article-title":"Therapeutic effects of curcumin and ursodexycholic acid on non-alcoholic fatty liver disease","volume":"115","author":"Gheibi","year":"2019","journal-title":"Biomed. Pharmacother."},{"issue":"3","key":"10.1016\/j.lfs.2023.121943_bb1400","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.bbrc.2020.05.128","article-title":"Ursodeoxycholic acid alleviates nonalcoholic fatty liver disease by inhibiting apoptosis and improving autophagy via activating AMPK","volume":"529","author":"Wu","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.lfs.2023.121943_bb1405","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1038\/s41598-023-28647-4","article-title":"Combinatorial therapy with BAR502 and UDCA resets FXR and GPBAR1 signaling and reverses liver histopathology in a model of NASH","volume":"13","author":"Marchian\u00f2","year":"2023","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.lfs.2023.121943_bb1410","doi-asserted-by":"crossref","DOI":"10.3390\/cells8030253","article-title":"Ursodeoxycholic acid regulates hepatic energy homeostasis and white adipose tissue macrophages polarization in leptin-deficiency obese mice","volume":"8","author":"Chen","year":"2019","journal-title":"Cells"},{"issue":"6","key":"10.1016\/j.lfs.2023.121943_bb1415","first-page":"1464","article-title":"Ursodeoxycholic acid or clofibrate in the treatment of non-alcohol-induced steatohepatitis: a pilot study","volume":"23","author":"Laurin","year":"1996","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.lfs.2023.121943_bb1420","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1002\/hep.20092","article-title":"Ursodeoxycholic acid for treatment of nonalcoholic steatohepatitis: results of a randomized trial","volume":"39","author":"Lindor","year":"2004","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.lfs.2023.121943_bb1425","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1002\/hep.23727","article-title":"High-dose ursodeoxycholic acid therapy for nonalcoholic steatohepatitis: a double-blind, randomized, placebo-controlled trial","volume":"52","author":"Leuschner","year":"2010","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.lfs.2023.121943_bb1430","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.jhep.2010.08.030","article-title":"A randomized controlled trial of high-dose ursodesoxycholic acid for nonalcoholic steatohepatitis","volume":"54","author":"Ratziu","year":"2011","journal-title":"J. Hepatol."},{"issue":"10","key":"10.1016\/j.lfs.2023.121943_bb1435","doi-asserted-by":"crossref","first-page":"959","DOI":"10.3748\/wjg.v27.i10.959","article-title":"Ursodeoxycholic acid as a means of preventing atherosclerosis, steatosis and liver fibrosis in patients with nonalcoholic fatty liver disease","volume":"27","author":"Nadinskaia","year":"2021","journal-title":"World J. Gastroenterol."},{"issue":"23","key":"10.1016\/j.lfs.2023.121943_bb1440","first-page":"7449","article-title":"A randomized controlled trial comparing the effects of vitamin E, Ursodeoxycholic acid and Pentoxifylline on Egyptian non-alcoholic steatohepatitis patients","volume":"25","author":"Fouda","year":"2021","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"issue":"6","key":"10.1016\/j.lfs.2023.121943_bb1445","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1080\/17474124.2022.2083605","article-title":"Efficiency of ursodeoxycholic acid for the treatment of nonalcoholic steatohepatitis: a systematic review and meta-analysis","volume":"16","author":"Lin","year":"2022","journal-title":"Expert Rev. Gastroenterol. Hepatol."},{"issue":"6","key":"10.1016\/j.lfs.2023.121943_bb1450","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1016\/j.jhep.2014.12.034","article-title":"Ursodeoxycholic acid exerts farnesoid X receptor-antagonistic effects on bile acid and lipid metabolism in morbid obesity","volume":"62","author":"Mueller","year":"2015","journal-title":"J. Hepatol."},{"issue":"3","key":"10.1016\/j.lfs.2023.121943_bb1455","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1111\/liv.13562","article-title":"Ursodeoxycholic acid: effects on hepatic unfolded protein response, apoptosis and oxidative stress in morbidly obese patients","volume":"38","author":"Mueller","year":"2018","journal-title":"Liver Int."},{"issue":"25","key":"10.1016\/j.lfs.2023.121943_bb1460","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1016\/S0024-3205(98)00511-6","article-title":"Ursodeoxycholate protects against ethanol-induced liver mitochondrial injury","volume":"63","author":"Tabouy","year":"1998","journal-title":"Life Sci."},{"issue":"3","key":"10.1016\/j.lfs.2023.121943_bb1465","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1159\/000454853","article-title":"Therapeutic mechanisms of bile acids and nor-ursodeoxycholic acid in non-alcoholic fatty liver disease","volume":"35","author":"Steinacher","year":"2017","journal-title":"Dig. Dis."},{"issue":"3","key":"10.1016\/j.lfs.2023.121943_bb1470","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1136\/gut.2010.223834","article-title":"Nor-ursodeoxycholic acid reverses hepatocyte-specific nemo-dependent steatohepatitis","volume":"60","author":"Beraza","year":"2011","journal-title":"Gut"},{"issue":"10","key":"10.1016\/j.lfs.2023.121943_bb1475","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/S2468-1253(19)30184-0","article-title":"Norursodeoxycholic acid versus placebo in the treatment of non-alcoholic fatty liver disease: a double-blind, randomised, placebo-controlled, phase 2 dose-finding trial","volume":"4","author":"Traussnigg","year":"2019","journal-title":"Lancet Gastroenterol. Hepatol."},{"issue":"1","key":"10.1016\/j.lfs.2023.121943_bb1480","doi-asserted-by":"crossref","first-page":"5503","DOI":"10.1038\/s41467-021-25701-5","article-title":"A phase 2, proof of concept, randomised controlled trial of berberine ursodeoxycholate in patients with presumed non-alcoholic steatohepatitis and type 2 diabetes","volume":"12","author":"Harrison","year":"2021","journal-title":"Nat. Commun."},{"issue":"10","key":"10.1016\/j.lfs.2023.121943_bb1485","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1080\/17474124.2016.1216784","article-title":"Obeticholic acid for the treatment of primary biliary cirrhosis","volume":"10","author":"Jones","year":"2016","journal-title":"Expert Rev. Gastroenterol. Hepatol."},{"issue":"5","key":"10.1016\/j.lfs.2023.121943_bb1490","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1053\/j.gastro.2020.07.036","article-title":"FXR isoforms control different metabolic functions in liver cells via binding to specific DNA motifs","volume":"159","author":"Ramos Pittol","year":"2020","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.lfs.2023.121943_bb1495","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1124\/mol.119.118646","article-title":"Obeticholic acid ameliorates valproic acid-induced hepatic steatosis and oxidative stress","volume":"97","author":"Gai","year":"2020","journal-title":"Mol. Pharmacol."},{"issue":"8","key":"10.1016\/j.lfs.2023.121943_bb1500","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1007\/s12272-016-0812-y","article-title":"Farnesoid X receptor as a regulator of fuel consumption and mitochondrial function","volume":"39","author":"Han","year":"2016","journal-title":"Arch. Pharm. Res."},{"issue":"1","key":"10.1016\/j.lfs.2023.121943_bb1505","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1093\/bmb\/ldaa006","article-title":"Obeticholic acid-a new therapy in PBC and NASH","volume":"133","author":"Chapman","year":"2020","journal-title":"Br. Med. Bull."},{"issue":"10215","key":"10.1016\/j.lfs.2023.121943_bb1510","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1016\/S0140-6736(19)33041-7","article-title":"Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial","volume":"394","author":"Younossi","year":"2019","journal-title":"Lancet (Lond. Engl.)"},{"issue":"3","key":"10.1016\/j.lfs.2023.121943_bb1515","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.jhep.2021.10.029","article-title":"Non-invasive evaluation of response to obeticholic acid in patients with NASH: results from the REGENERATE study","volume":"76","author":"Rinella","year":"2022","journal-title":"J. Hepatol."},{"issue":"9","key":"10.1016\/j.lfs.2023.121943_bb1520","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1016\/j.cgh.2021.07.020","article-title":"Obeticholic acid impact on quality of life in patients with nonalcoholic steatohepatitis: REGENERATE 18-month interim analysis","volume":"20","author":"Younossi","year":"2022","journal-title":"Clin. Gastroenterol. Hepatol."},{"issue":"1","key":"10.1016\/j.lfs.2023.121943_bb1525","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.dld.2020.08.021","article-title":"Antidiabetic drugs and non-alcoholic fatty liver disease: a systematic review, meta-analysis and evidence map","volume":"53","author":"Kumar","year":"2021","journal-title":"Dig. Liver Dis."},{"issue":"11","key":"10.1016\/j.lfs.2023.121943_bb1530","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s11892-020-01349-1","article-title":"Role of agents for the treatment of diabetes in the management of nonalcoholic fatty liver disease","volume":"20","author":"Budd","year":"2020","journal-title":"Curr. Diabetes Rep."},{"issue":"19","key":"10.1016\/j.lfs.2023.121943_bb1535","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1001\/jama.2019.3805","article-title":"Metformin in 2019","volume":"321","author":"Flory","year":"2019","journal-title":"Jama"},{"issue":"10","key":"10.1016\/j.lfs.2023.121943_bb1540","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19102863","article-title":"Metformin: an old drug with new applications","volume":"19","author":"Zhou","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"43","key":"10.1016\/j.lfs.2023.121943_bb1545","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000031437","article-title":"Effect of metformin on nonalcoholic fatty liver based on meta-analysis and network pharmacology","volume":"101","author":"Huang","year":"2022","journal-title":"Medicine"},{"issue":"6","key":"10.1016\/j.lfs.2023.121943_bb1550","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1016\/j.celrep.2019.09.070","article-title":"Metformin improves mitochondrial respiratory activity through activation of AMPK","volume":"29","author":"Wang","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.lfs.2023.121943_bb1555","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1016\/j.biopha.2019.01.021","article-title":"Metformin enhances mitochondrial biogenesis and thermogenesis in brown adipocytes of mice","volume":"111","author":"Karise","year":"2019","journal-title":"Biomed. Pharmacother."},{"issue":"2","key":"10.1016\/j.lfs.2023.121943_bb1560","doi-asserted-by":"crossref","first-page":"121","DOI":"10.36290\/vnl.2020.020","article-title":"Pioglitazone","volume":"66","author":"Kar\u00e1sek","year":"2020","journal-title":"Vnitr. Lek."},{"issue":"46","key":"10.1016\/j.lfs.2023.121943_bb1565","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000031508","article-title":"Pioglitazone on nonalcoholic steatohepatitis: a systematic review and meta-analysis of 15 RCTs","volume":"101","author":"Zhao","year":"2022","journal-title":"Medicine"},{"key":"10.1016\/j.lfs.2023.121943_bb1570","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.615409","article-title":"Pioglitazone for NAFLD patients with prediabetes or type 2 diabetes mellitus: a meta-analysis","volume":"12","author":"Lian","year":"2021","journal-title":"Front. Endocrinol."},{"issue":"2","key":"10.1016\/j.lfs.2023.121943_bb1575","doi-asserted-by":"crossref","first-page":"E163","DOI":"10.1152\/ajpendo.00023.2018","article-title":"Pioglitazone improves hepatic mitochondrial function in a mouse model of nonalcoholic steatohepatitis","volume":"315","author":"Kalavalapalli","year":"2018","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.lfs.2023.121943_bb1580","article-title":"Pioglitazone inhibits diabetes-induced atrial mitochondrial oxidative stress and improves mitochondrial biogenesis, dynamics, and function through the PPAR-\u03b3\/PGC-1\u03b1 signaling pathway","volume":"12","author":"Zhang","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.lfs.2023.121943_bb1585","doi-asserted-by":"crossref","first-page":"545","DOI":"10.3389\/fphar.2017.00545","article-title":"Pioglitazone improves mitochondrial function in the remnant kidney and protects against renal fibrosis in 5\/6 nephrectomized rats","volume":"8","author":"Sun","year":"2017","journal-title":"Front. Pharmacol."},{"issue":"Suppl. 3","key":"10.1016\/j.lfs.2023.121943_bb1590","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/dom.14487","article-title":"Recent developments in GLP-1RA therapy: a review of the latest evidence of efficacy and safety and differences within the class","volume":"23","author":"Bain","year":"2021","journal-title":"Diabetes Obes. Metab."},{"issue":"Suppl. 1","key":"10.1016\/j.lfs.2023.121943_bb1595","doi-asserted-by":"crossref","first-page":"2s28","DOI":"10.1016\/S1262-3636(17)30070-8","article-title":"GLP-1 receptor agonists in NAFLD","volume":"43","author":"Petit","year":"2017","journal-title":"Diabetes Metab."},{"issue":"1","key":"10.1016\/j.lfs.2023.121943_bb1600","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1210\/clinem\/dgab578","article-title":"The emerging role of glucagon-like peptide-1 receptor agonists for the management of NAFLD","volume":"107","author":"Patel Chavez","year":"2022","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"10019","key":"10.1016\/j.lfs.2023.121943_bb1605","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/S0140-6736(15)00803-X","article-title":"Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study","volume":"387","author":"Armstrong","year":"2016","journal-title":"Lancet (Lond. Engl.)"},{"issue":"27","key":"10.1016\/j.lfs.2023.121943_bb1610","doi-asserted-by":"crossref","first-page":"9090","DOI":"10.3748\/wjg.v20.i27.9090","article-title":"Potential roles of glucagon-like peptide-1-based therapies in treating non-alcoholic fatty liver disease","volume":"20","author":"Liu","year":"2014","journal-title":"World J. Gastroenterol."},{"issue":"2","key":"10.1016\/j.lfs.2023.121943_bb1615","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/dom.14565","article-title":"Effects of glucagon-like peptide-1 receptor agonists on histopathological and secondary biomarkers of non-alcoholic steatohepatitis: a systematic review and meta-analysis","volume":"24","author":"Borodavkin","year":"2022","journal-title":"Diabetes Obes. Metab."},{"issue":"7","key":"10.1016\/j.lfs.2023.121943_bb1620","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1111\/apt.16583","article-title":"Systematic review with network meta-analysis: comparative efficacy of pharmacologic therapies for fibrosis improvement and resolution of NASH","volume":"54","author":"Majzoub","year":"2021","journal-title":"Aliment. Pharmacol. Ther."},{"issue":"3","key":"10.1016\/j.lfs.2023.121943_bb1625","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1080\/17474124.2023.2172397","volume":"17","author":"Gu","year":"2023","journal-title":"Expert Rev. Gastroenterol. Hepatol."},{"issue":"6","key":"10.1016\/j.lfs.2023.121943_bb1630","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.cmet.2020.05.001","article-title":"GLP-1 receptor signaling in astrocytes regulates fatty acid oxidation, mitochondrial integrity, and function","volume":"31","author":"Timper","year":"2020","journal-title":"Cell Metab."},{"issue":"9","key":"10.1016\/j.lfs.2023.121943_bb1635","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1111\/hepr.12634","article-title":"Liraglutide ameliorates non-alcoholic fatty liver disease by enhancing mitochondrial architecture and promoting autophagy through the SIRT1\/SIRT3-FOXO3a pathway","volume":"46","author":"Tong","year":"2016","journal-title":"Hepatol. Res."},{"issue":"1","key":"10.1016\/j.lfs.2023.121943_bb1640","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1007\/s12640-021-00460-9","article-title":"Liraglutide regulates mitochondrial quality control system through PGC-1\u03b1 in a mouse model of Parkinson\u2019s disease","volume":"40","author":"Wu","year":"2022","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.lfs.2023.121943_bb1645","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1146\/annurev-med-051013-110046","article-title":"The mechanisms and therapeutic potential of SGLT2 inhibitors in diabetes mellitus","volume":"66","author":"Vallon","year":"2015","journal-title":"Annu. Rev. Med."},{"issue":"4","key":"10.1016\/j.lfs.2023.121943_bb1650","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s40261-016-0383-1","volume":"36","author":"Ohki","year":"2016","journal-title":"Clin. Drug Investig."},{"issue":"5","key":"10.1016\/j.lfs.2023.121943_bb1655","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/hepr.13304","article-title":"Impact of sodium glucose cotransporter 2 inhibitor on histological features and glucose metabolism of non-alcoholic fatty liver disease complicated by diabetes mellitus","volume":"49","author":"Akuta","year":"2019","journal-title":"Hepatol. Res."},{"issue":"2","key":"10.1016\/j.lfs.2023.121943_bb1660","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/dom.13520","article-title":"Evaluation of the effects of dapagliflozin, a sodium-glucose co-transporter-2 inhibitor, on hepatic steatosis and fibrosis using transient elastography in patients with type 2 diabetes and non-alcoholic fatty liver disease","volume":"21","author":"Shimizu","year":"2019","journal-title":"Diabetes Obes. Metab."},{"issue":"8","key":"10.1016\/j.lfs.2023.121943_bb1665","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.2337\/dc18-0165","article-title":"Effect of empagliflozin on liver fat in patients with type 2 diabetes and nonalcoholic fatty liver disease: a randomized controlled trial (E-LIFT trial)","volume":"41","author":"Kuchay","year":"2018","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.lfs.2023.121943_bb1670","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/hepr.13236","article-title":"Effect of luseogliflozin on hepatic fat content in type 2 diabetes patients with non-alcoholic fatty liver disease: a prospective, single-arm trial (LEAD trial)","volume":"49","author":"Sumida","year":"2019","journal-title":"Hepatol. Res."},{"issue":"4","key":"10.1016\/j.lfs.2023.121943_bb1675","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.dld.2021.08.017","article-title":"The safety and efficacy evaluation of sodium-glucose co-transporter 2 inhibitors for patients with non-alcoholic fatty liver disease: an updated meta-analysis","volume":"54","author":"Mo","year":"2022","journal-title":"Dig. Liver Dis."},{"key":"10.1016\/j.lfs.2023.121943_bb1680","doi-asserted-by":"crossref","first-page":"186","DOI":"10.3389\/fcvm.2019.00186","article-title":"SGLT2 inhibitors play a salutary role in heart failure via modulation of the mitochondrial function","volume":"6","author":"Maejima","year":"2019","journal-title":"Front. Cardiovasc. Med."},{"issue":"4","key":"10.1016\/j.lfs.2023.121943_bb1685","doi-asserted-by":"crossref","first-page":"F767","DOI":"10.1152\/ajprenal.00565.2018","article-title":"Empagliflozin attenuates diabetic tubulopathy by improving mitochondrial fragmentation and autophagy","volume":"317","author":"Lee","year":"2019","journal-title":"Am. J. Physiol. Ren. Physiol."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320523005787?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320523005787?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T19:42:17Z","timestamp":1736365337000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320523005787"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":337,"alternative-id":["S0024320523005787"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2023.121943","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The emerging significance of mitochondrial targeted strategies in NAFLD treatment","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2023.121943","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"121943"}}